A
ARKG
Productby ARK Investment Management
Heard in 5 episodes across 1 show since Sep 2026
ARKG is the ARK Genomic Revolution ETF, an exchange-traded fund focused on companies involved in genomics, biotechnology, and related healthcare innovation.
Episodes
5
across 1 show
First heard
Sep 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
3
2
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 3 |
| Oct 2026 | 2 |
Episodes
5 episodes featuring ARKG, newest first
- Oct 7, 2026
Mega-cap strength masks widening market weaknessStock Market Today With IBDOct 7, 2026 - Oct 6, 2026
Broad rally tests whether market breadth can keep paceStock Market Today With IBDOct 6, 2026 - Sep 25, 2026
Growth stocks rebound as investors weigh fragile market breadthStock Market Today With IBDSep 25, 2026 - Sep 17, 2026
Market rebound tests whether leadership can broadenStock Market Today With IBDSep 17, 2026 - Sep 14, 2026
Sideways market rewards discipline as software and defensives leadStock Market Today With IBDSep 14, 2026